Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Melinda Gooderham; Robert Bissonnette; Sunil Kalia; Kim Papp; Lyn Guenther; Wayne Gulliver; Vincent Ho; Neil H. Shear; Ronald Vender; Robert Gniadecki; Vimal H. Prajapati; Irina Turchin; Wayne Langholff; Kim Parnell; S Simpson; Nastaran Abbarin; Omair Lakhani; Raed Alhusayen

doi:10.1177/12034754231191509

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

The Canadian subgroup of PSOLAR patients was generally similar to those enrolled globally with respect to baseline disease demographics and clinical characteristics. Multiple comorbidities are noted in the Canadian subgroup, underscoring the need for a holistic approach to the treatment of psoriatic patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gooderham et al. (2023) studied this question.

synapsesocial.com/papers/69d68d6d3db2fe4b91db8294 https://doi.org/10.1177/12034754231191509

View Full Paper

Ask AI

Bookmark

Share

Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Ask about this paper

Abstract

Discussion

Cite This Study

Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading